Toshiaki Kadokami

ORCID: 0000-0001-9017-700X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiac Imaging and Diagnostics
  • Diabetes Treatment and Management
  • Heart Failure Treatment and Management
  • Cardiovascular Function and Risk Factors
  • Heart Rate Variability and Autonomic Control
  • Advanced MRI Techniques and Applications
  • Cardiovascular and exercise physiology
  • Obstructive Sleep Apnea Research
  • Cardiac electrophysiology and arrhythmias
  • Cardiac Fibrosis and Remodeling
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Viral Infections and Immunology Research
  • Lipoproteins and Cardiovascular Health
  • Acute Myocardial Infarction Research
  • Neuroscience of respiration and sleep
  • Blood Pressure and Hypertension Studies
  • Atrial Fibrillation Management and Outcomes
  • Hemodynamic Monitoring and Therapy
  • Cardiovascular Disease and Adiposity
  • Metabolism, Diabetes, and Cancer
  • Nitric Oxide and Endothelin Effects
  • Atherosclerosis and Cardiovascular Diseases
  • Respiratory Support and Mechanisms
  • Cardiac Arrest and Resuscitation
  • Coronary Interventions and Diagnostics

Fukui-ken Saiseikai Hospital
2015-2024

Saiseikai Fukuoka General Hospital
2020-2022

Japanese Circulation Society
2015-2019

Kyushu Hospital
2016-2017

Kyushu University Hospital
2016

St Mary's Hospital
2016

Japanese Red Cross Fukuoka Hospital
2016

Kyushu University
1995-2010

Jefferson College
2005

University of Pittsburgh
2000-2003

Studies in vitro have suggested that inflammatory cytokines may play an important role the pathogenesis of atherosclerosis. However, little is known about their effects vivo. Thus, present study was designed to determine vivo what histological and functional changes be induced by chronic treatment with IL-1 beta, one major cytokines, also clarify mechanisms are involved those changes. Under aseptic conditions, proximal segments left porcine coronary arteries were gently wrapped cotton mesh...

10.1172/jci118476 article EN Journal of Clinical Investigation 1996-02-01

Abstract The aim of the present study was to investigate effects long-term blockade nitric oxide synthesis with l -arginine analogue N ω −nitro- methyl ester (L-NAME) for 8 weeks on coronary vascular and myocardial structural changes. Four groups Wistar-Kyoto rats were studied: those no treatment, treated L-NAME 1 g/L (3.7 mmol/L in drinking water), 0.1 (0.37 1.0 hydralazine 120 mg/L (0.6 water). After weeks, heart excised, degrees changes arteries (wall-to-lumen ratio perivascular...

10.1161/01.hyp.26.6.957 article EN Hypertension 1995-12-01

Background —Transgenic mice with cardiac-specific overexpression of tumor necrosis factor (TNF)-α develop dilated cardiomyopathy. The present study was designed to evaluate therapeutic effects adenovirus-mediated neutralization TNF-α on this model. Methods and Results —An adenovirus encoding the 55-kDa TNF receptor–IgG fusion protein (AdTNFRI) injected intravenously into 6-week-old transgenic mice, which resulted in high levels TNFRI both plasma myocardium. AdTNFRI did not reverse...

10.1161/01.cir.101.21.2518 article EN Circulation 2000-05-30

Epidemiological evidence suggests that the prognosis of heart failure in women is better than men. In our murine model dilated cardiomyopathy arising from cardiac-specific overexpression TNF-α, 6-month survival rate was significantly females males. Young female transgenic mice exhibited left ventricular wall thickening without dilatation, whereas age-matched male hearts were markedly dilated. Basal and isoproterenol-stimulated fractional shortening preserved mice, but not mice. Myocardial...

10.1172/jci9307 article EN Journal of Clinical Investigation 2000-08-15

Abstract Objectives Coronary microvascular functional and structural obstructions (CMVO) after percutaneous coronary intervention (PCI) are a major cause of poor clinical outcomes in patients with acute syndrome. This study aimed to noninvasively diagnose the presence CMVO using non-contrast multiparametric cardiac magnetic resonance (CMR) myocardial infarction (AMI) who underwent PCI. Methods We retrospectively enrolled consecutive AMI PCI subsequent acute-phase CMR at our hospital. The...

10.1007/s00330-025-11496-2 article EN cc-by European Radiology 2025-03-17

Background — Tumor necrosis factor (TNF)-α has been implicated in the pathophysiology of congestive heart failure. A strain transgenic mice (TNF1.6) with cardiac-specific overexpression TNF-α develop Methods and Results To determine effect anti-TNF-α therapy this model, we studied 3 groups: TNF1.6 treated saline, wild-type neutralizing antibody (cV1q) from 6 to 12 weeks age. We used echocardiography compare cardiac hypertrophy, function, catecholamine response at age versus baseline (6...

10.1161/hc3501.096063 article EN Circulation 2001-09-04

Background Endothelium-derived nitric oxide (NO) is believed to regulate myocardial perfusion and structural changes in the vascular wall. Our objective was determine whether chronic inhibition of NO synthesis causes functional coronary arteries. Methods Results Coronary vasomotor response studied pigs before after oral administration antagonist N ω -nitro- l -arginine methyl ester (L-NAME) 30 mg · kg −1 d for 2 weeks. Chronic L-NAME treatment increased ( P <.01) arterial pressure but did...

10.1161/01.cir.92.9.2636 article EN Circulation 1995-11-01

We sought to investigate whether treatment with ezetimibe in combination statins improves coronary endothelial function target vessels artery disease patients after stenting.We conducted a multicenter, prospective, randomized, open-label, blinded-end point trial among 11 cardiovascular centers. From 2011 2013, 260 who underwent stenting were randomly allocated 2 arms (statin monotherapy, S versus [10 mg/d]+statin combinational therapy, E+S). defined vessel dysfunction as the primary...

10.1161/atvbaha.116.308388 article EN Arteriosclerosis Thrombosis and Vascular Biology 2016-12-09
Atsushi Tanaka Masataka Sata Yosuke Okada Hiroki Teragawa Katsumi Eguchi and 95 more Michio Shimabukuro Isao Taguchi Kazuo Matsunaga Yumiko Kanzaki Hisako Yoshida Tomoko Ishizu Shinichiro Ueda Masafumi Kitakaze Toyoaki Murohara Koichi Node Koichi Node Toyoaki Murohara Masafumi Kitakaze Yoshihiko Nishio Teruo Inoue Mitsuru Ohishi Kazuomi Kario Masataka Sata Michio Shimabukuro Wataru Shimizu Hideaki Jinnouchi Isao Taguchi Hirofumi Tomiyama Koji Maemura Makoto Suzuki Shin‐ichi Ando Katsumi Eguchi Haruo Kamiya Tomohiro Sakamoto Hiroki Teragawa Mamoru Nanasato Munehide Matsuhisa Junya Ako Yoshimasa Aso Masaharu Ishihara Kazuo Kitagawa Akira Yamashina Tomoko Ishizu Yumi Ikehara Shinichiro Ueda Ayako Takamori Atsushi Tanaka Miki Mori Kaori Yamaguchi Machiko Asaka Tetsuya Kaneko Masashi Sakuma Shigeru Toyoda Takahisa Nasuno Michiya Kageyama Teruo Jojima Toshie Iijima Haruka Kishi Hirotsugu Yamada Kenya Kusunose Daiju Fukuda Shusuke Yagi Koji Yamaguchi Takayuki Ise Yutaka Kawabata Akio Kuroda Yuichi Akasaki Mihoko Kurano Satoshi Hoshide Takahiro Komori Tomoyuki Kabutoya Yukiyo Ogata Yuji Koide Hiroaki Kawano Satoshi Ikeda Satoki Fukae Seiji Koga Yukihito Higashi Shinji Kishimoto Masato Kajikawa Tatsuya Maruhashi Yoshiaki Kubota Yoshisato Shibata Nehiro Kuriyama Ikuko Nakamura Kanemitsu Hironori Bonpei Takase Yuichi Orita Chikage Oshita Yuko Uchimura Ruka Yoshida Yukihiko Yoshida Hirohiko Suzuki Yasuhiro Ogura Mayuho Maeda Masaki Takenaka Takumi Hayashi Mirai Hirose Itaru Hisauchi Toshiaki Kadokami

Abstract Aims To examine the effects of a 24-month treatment with ipragliflozin on carotid intima-media thickness (IMT) in type 2 diabetes patients. Methods and results In this multicenter, prospective, randomized, open-label, blinded-endpoint investigator-initiated clinical trial, adults haemoglobin A1C (HbA1c) 6.0–10.0% (42–86 mmol/mol) were randomized equally to (50 mg daily) non-sodium-glucose cotransporter-2 (SGLT2) inhibitor use standard-care (control group) for followed-up 24 months....

10.1093/ehjcvp/pvac059 article EN cc-by-nc European Heart Journal - Cardiovascular Pharmacotherapy 2022-10-29

We recently developed a porcine model in which chronic, local treatment with interleukin-1β (IL-1β) causes coronary arteriosclerosis-like changes and hyperconstrictive responses. This study was designed to examine whether or not other major inflammatory cytokines [tumor necrosis factor-α (TNF-α) interleukin-1α (IL-1α)] might also cause similar responses those are associated alterations the smooth-muscle phenotypes. A segment of artery aseptically wrapped cotton mesh, absorbing IL-1β, TNF-α,...

10.1097/00005344-199702000-00011 article EN Journal of Cardiovascular Pharmacology 1997-02-01

Myocardial extracellular matrix remodeling regulated by metalloproteinases (MMPs) is implicated in the progression of heart failure. We hypothesized that MMP inhibition may modulate and prevent The effects inhibitor BB-94 (also known as batimastat) on expression, collagen deposition, denaturation, left ventricular structure function transgenic mice with cardiac-restricted overexpression tumor necrosis factor-α (TNF-α) (TNF1.6) were assessed. results showed reduced expression collagens,...

10.1152/ajpheart.00233.2001 article EN AJP Heart and Circulatory Physiology 2002-03-01

Transgenic (TG) TNF1.6 mice, which cardiac specifically overexpress tumor necrosis factor-alpha (TNF-alpha), exhibit heart failure (HF) and increased mortality, is markedly higher in young (<20 wk) males (TG-M) than females (TG-F). HF this model may be partly caused by remodeling of the extracellular matrix and/or structure/function alterations at single myocyte level. We studied left ventricular (LV) structure function using echocardiography LV morphometry, contractile function,...

10.1152/ajpheart.0718.2001 article EN AJP Heart and Circulatory Physiology 2003-03-01

Abstract Introduction Dotinurad is a newer urate-lowering agent that selectively inhibits urate transporter 1 in the renal proximal tubule and increases urinary excretion. Currently, little known about clinical efficacies of dotinurad patients with hyperuricemia hypertension. The aim this study was to assess effects selective reabsorption inhibitor on serum uric acid (SUA) levels relevant vascular markers treated Methods This investigator-initiated, multicenter, prospective, single-arm,...

10.1186/s40001-023-01208-1 article EN cc-by European journal of medical research 2023-07-17

Tumor necrosis factor (TNF)-alpha plays a key role in the pathogenesis of septic shock syndrome, and myocardial TNF-alpha expression may contribute to this pathophysiology. We examined TNF-alpha-related cytokines chemokines mice exposed lipopolysaccharide (LPS) tested effects anti-TNF therapy on cytokine expression. Cytokine mRNA levels were measured by RNase protection assay, protein plasma myocardium assessed enzyme-linked immunosorbent assays. LPS (4 microg/g body wt ip) induced marked...

10.1152/ajpheart.2001.280.5.h2281 article EN AJP Heart and Circulatory Physiology 2001-05-01

Background The intracellular mechanism for coronary artery spasm is still unknown. Since the protein kinase C (PKC)–mediated pathway and Ca 2+ release from sarcoplasmic reticulum (SR) are important mechanisms of vascular smooth muscle contraction, we examined possible role these two in pathogenesis our swine model vivo. Methods Results In 25 pigs, interleukin-1β (IL-1β) was applied chronically to arteries adventitia induce an inflammatory/proliferative lesion. Two weeks after operation,...

10.1161/01.cir.94.2.190 article EN Circulation 1996-07-15

Background: We have previously demonstrated that the prevalence of metabolic syndrome in chronic heart failure (CHF) is more than double compared with general population Japan. However, impact physical activity on cardiovascular events CHF patients remains to be fully elucidated. Methods and Results: performed a prospective, nationwide large-scale multicenter study 9,178 stage A/B/C/D obtained baseline data for 7,292 yearly changes during 3-year follow-up period 4,353 patients. divided into...

10.1253/circj.cj-13-0746 article EN Circulation Journal 2013-01-01

Type 2 diabetes mellitus is associated strongly with an increased risk of micro- and macro-vascular complications, leading to impaired quality life shortened expectancy. In addition appropriate glycemic control, multi-factorial intervention for a wide range factors, such as hypertension dyslipidemia, crucial management diabetes. A recent cardiovascular outcome trial in patients higher demonstrated that SGLT2 inhibitor markedly reduced mortality, but not events. However, date there no...

10.1186/s12933-016-0449-7 article EN cc-by Cardiovascular Diabetology 2016-09-13

Background We recently developed a porcine model in which chronic, local treatment with interleukin-1β (IL-1β) causes coronary arteriosclerotic changes and hyperconstrictive responses. Inflammatory cytokines are known to induce inducible NO synthase (iNOS) the vascular smooth muscle. This study was designed examine whether or not production of by iNOS has protective deleterious effect on artery vivo. Methods Results A segment aseptically wrapped cotton mesh absorbing IL-1β suspension....

10.1161/01.cir.96.9.3104 article EN Circulation 1997-11-04

The aim of this study was to validate a four-parameter risk model including 123I-meta-iodobenzylguanidine (MIBG) imaging, which previously developed for predicting cardiac mortality, in new cohort patients with chronic heart failure (CHF). Clinical and outcome data were retrospectively obtained from 546 (age 66 ± 14 years) who had undergone 123I-MIBG imaging heart-to-mediastinum ratio (HMR). mean follow-up time 30 20 months, the endpoint death. mortality predicted by compared actual 2-year...

10.1093/ehjci/jey016 article EN cc-by-nc European Heart Journal - Cardiovascular Imaging 2018-01-16

We recently demonstrated that chronic treatment with IL-1 beta induces coronary arteriosclerotic changes and vasospastic responses to autacoids in pigs vivo those are importantly mediated by PDGF. The receptors for PDGF other major growth factors known have tyrosine kinase activity. therefore investigated the effects of a selective inhibitor, ST 638, on induced our swine model. Intimal thickening serotonin histamine were at site artery where was chronically locally applied. These...

10.1172/jci118163 article EN Journal of Clinical Investigation 1995-09-01
Coming Soon ...